Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for human disease has been reported in the published literature.
No clinical trials have been registered for human disease.
299 publications have been identified in PubMed for human disease. Research spans Review / Meta-Analysis (65%), Basic Science / Preclinical (15%), and Other (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 162 | 65% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 7:12 PM UTC
37 |
15% |
Other research | 25 | 10% |
Disease patterns and progression | 16 | 6% |
New treatment approaches | 6 | 2% |
Testing and diagnosis research | 3 | 1% |
Patient case studies | 2 | 1% |
Kim YI (2026). [PMID: 41755768](https://pubmed.ncbi.nlm.nih.gov/41755768/). *Biomol Ther (Seoul)*. [Review / Meta-Analysis]
Vuong HL (2026). [PMID: 42191275](https://pubmed.ncbi.nlm.nih.gov/42191275/). *Int Rev Cell Mol Biol*. [Review / Meta-Analysis]
Ho JSY (2026). [PMID: 42276034](https://pubmed.ncbi.nlm.nih.gov/42276034/). *Cell*. [Review / Meta-Analysis]
Zhang P (2026). [PMID: 41797994](https://pubmed.ncbi.nlm.nih.gov/41797994/). *Front Mol Biosci*. [Other]
Pandey SK (2026). [PMID: 41572755](https://pubmed.ncbi.nlm.nih.gov/41572755/). *Curr Mol Med*. [Basic Science / Preclinical]
Heller EA (2026). [PMID: 41286458](https://pubmed.ncbi.nlm.nih.gov/41286458/). *Nat Rev Drug Discov*. [Review / Meta-Analysis]
Sinha IR (2026). [PMID: 42135847](https://pubmed.ncbi.nlm.nih.gov/42135847/). *Mol Neurodegener*. [Review / Meta-Analysis]
Mani K (2026). [PMID: 41977142](https://pubmed.ncbi.nlm.nih.gov/41977142/). *Int J Mol Sci*. [Other]
Engwerda CR (2026). [PMID: 42020513](https://pubmed.ncbi.nlm.nih.gov/42020513/). *Nat Rev Immunol*. [Review / Meta-Analysis]
Haidurov A (2026). [PMID: 41972739](https://pubmed.ncbi.nlm.nih.gov/41972739/). *Cells*. [Review / Meta-Analysis]